The Journal of bone and joint surgery. American volume
September 15, 2026 · via Europe PMC
Robotic Arthroplasty in Context: Balancing Evidence and Innovation in Joint Replacement.
Fraval A, Rajgopal A, Bozic KJ, Bhandari M, Parvizi J.
AI summary — for doctors, generated from the abstract only
This review article concludes that while robotic-assisted joint replacement surgery improves the precision of implant positioning, it has not consistently been shown to improve patient-reported outcomes, complication rates, or implant survival compared with conventional techniques.
What was studied
Not a primary data study — this is a review article examining the current evidence on robotic-assisted joint replacement (arthroplasty), covering its effects on surgical precision, clinical outcomes, and implant survivorship, synthesizing findings from systematic reviews, meta-analyses, randomized trials, and national registry data.
Key findings
- This is a review synthesizing existing literature rather than new patient data, so no new outcome statistics specific to a single study are reported in the abstract.
- Current evidence consistently shows robotic-assisted arthroplasty improves the precision and reproducibility of implant component positioning.
- However, systematic reviews, meta-analyses, randomized trials, and registry data have not consistently shown improvements in patient-reported outcomes, complication rates, or implant survivorship with robotic assistance compared with conventional surgery.
- The review notes the existing literature is limited by statistical fragility, heterogeneity across different robotic platforms, and a disconnect between the scientific evidence base and public/market enthusiasm for the technology.
Clinical relevance
The findings are directly relevant to patients and surgeons considering robotic-assisted joint replacement, suggesting that while the technology improves technical precision, this has not yet translated into clearly better patient outcomes, which is important context for informed decision-making and for how healthcare systems evaluate adoption of this technology.
Who should care
Limitations
This is a narrative review rather than a new systematic review or meta-analysis with pooled statistics; its conclusions reflect synthesis of existing (and sometimes limited or heterogeneous) evidence rather than new primary data generated by the authors.
Robotic-assisted joint replacement improves surgical precision but has not been consistently shown to improve patient outcomes, complications, or implant survival compared with conventional surgery, according to this evidence review.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.
Abstract
➢ This review examines the contemporary evidence surrounding robotic-assisted joint replacement, including its effects on surgical precision, clinical outcomes, and implant survivorship, and the broader implications for innovation in arthroplasty.➢ Current evidence consistently demonstrates that robotic-assisted arthroplasty improves the precision and reproducibility of component positioning. However, systematic reviews, meta-analyses, randomized trials, and national registry data have not demonstrated consistent improvements in patient-reported outcomes, complication rates, or implant survivorship.➢ The existing literature is limited by statistical fragility, heterogeneity among robotic platforms, and a disconnect between scientific evidence and public enthusiasm.➢ Future value may lie in the integration of robotics with large-scale data acquisition and data-driven personalization, although these concepts remain largely unproven.➢ The experience of robotic-assisted arthroplasty highlights the need for a more rigorous evidence-based framework for innovation in orthopaedic surgery, with adoption guided by demonstrable improvements in patient outcomes and health-care value rather than technical precision alone.
DOI
10.2106/jbjs.26.00706
PMID
42743254
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed